1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for Japan
Induced Pluripotent Stem Cells Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in Japan
Induced Pluripotent Stem Cells Market
4.
Japan Induced Pluripotent Stem
Cells Market by Derived Cell Type
4.1.
Fibroblasts
4.2.
Amniotic Cells
4.3.
Hepatocytes
4.4.
Keratinocytes
4.5.
Others
5.
Japan Induced Pluripotent Stem
Cells Market by Application
5.1.
Drug Development
5.2.
Regenerative Medicine
5.3.
Toxicity Testing
5.4.
Academic Research
6.
Japan Induced Pluripotent Stem
Cells Market by End User
6.1.
Research Organizations
6.2. Hospitals
6.3.
Bio-pharma
Industries
7.
Company Profiles
7.1.
Company 1
7.2.
Company 2
7.3.
Company 3
7.4.
Company 4
7.5.
Company 5
1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for Japan
Induced Pluripotent Stem Cells Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in Japan
Induced Pluripotent Stem Cells Market
4.
Japan Induced Pluripotent Stem
Cells Market by Derived Cell Type
4.1.
Fibroblasts
4.2.
Amniotic Cells
4.3.
Hepatocytes
4.4.
Keratinocytes
4.5.
Others
5.
Japan Induced Pluripotent Stem
Cells Market by Application
5.1.
Drug Development
5.2.
Regenerative Medicine
5.3.
Toxicity Testing
5.4.
Academic Research
6.
Japan Induced Pluripotent Stem
Cells Market by End User
6.1.
Research Organizations
6.2. Hospitals
6.3.
Bio-pharma
Industries
7.
Company Profiles
7.1.
Company 1
7.2.
Company 2
7.3.
Company 3
7.4.
Company 4
7.5.
Company 5